June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

12.1 Million NCI Grant Awarded For Melanoma Research at Wistar Institute

Melanoma

Melanoma research has been gaining a lot of momentum through a number of recent US FDA approvals and Orphan Drug Designations for highly promising, novel treatments for this fatal type ... Read more

September 18, 2014September 18, 2014

Study Shows Experimental Drug PV-10 Results In Complete Response In 50% Of Melanoma Patients

News

Two studies entitled “Efficacy of intralesional rose bengal in patients receiving injection in all existing melanoma in phase II study PV-10-MM-02” and “Assessment of immune and clinical efficacy after intralesional ... Read more

September 17, 2014September 17, 2014

Breakthrough Advanced Melanoma Treatment Approved by Health Canada

News

Immunotherapy is fast becoming the treatment of choice for many types of cancer as it offers a more natural method to target cancer cells. Canadian melanoma patients received great news ... Read more

September 16, 2014September 16, 2014

Study Shows Possible Link between Viagra and Risk for Melanoma

Melanoma, News

A study entitled “Sildenafil Use and Increased Risk of Incident Melanoma in US Men, A Prospective Cohort Study” and published in the JAMA Internal Medicine journal has shown that there ... Read more

September 15, 2014September 15, 2014

MD Anderson Co-hosts Night Fun Run for Melanoma

Melanoma, News

Melanoma, the most serious type of skin cancer, is expected to be diagnosed in over 76,000 new cases of skin cancer this year alone. In order to raise funds for much needed ... Read more

September 12, 2014September 12, 2014

Study Finds Link Between Genetic Mutation and Melanoma Progression

Melanoma, News

In a study entitled, “BRAFV600E melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity” published in the British Journal of Cancer, scientists from Dartmouth-Hitchcock Norris Cotton Cancer Center in ... Read more

September 11, 2014September 11, 2014

Myriad myPath Melanoma Reduces Indeterminate Diagnosis and May Correct Treatment Recommendations

Melanoma, News

Molecular diagnostic company Myriad Genetics recently presented the results of its pivotal clinical utility study of the Myriad myPath Melanoma test, a new diagnostic tool for determining if a tissue is a malignant melanoma or ... Read more

September 10, 2014September 10, 2014

Melanoma Diagnosis Part of New, Advanced Broad-Spectrum Cancer Detection and Monitoring Platform

Melanoma, News

Aethlon Medical, Inc. and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), have announced that ESI researchers developed and validated a lectin-based diagnostic platform that can isolate exosome-based biomarkers common to several ... Read more

September 9, 2014September 9, 2014

JAMA Dermatology Advocates Changes in Healthcare Melanoma Screening

Melanoma, News

The monthly peer-reviewed medical journal published by the American Medical Association recently advocated changes to the way the nation’s melanoma screens are performed within the healthcare system, considering that there is $2.85 billion in overall lost productivity to the entire economy, in ... Read more

September 8, 2014September 8, 2014

Melanoma Risk Higher for Flight Crews, According to Study

Melanoma, News

A new study entitled “The Risk of Melanoma in Airline Pilots and Cabin Crew” published in the JAMA Dermatology journal has found that pilots and cabin crew members are 2.22 ... Read more

September 4, 2014September 5, 2014

Breakthrough Melanoma Treatment Approved by FDA

Melanoma, News, Skin Cancer

It is estimated that roughly 5% of all newly diagnosed cancers in America are melanomas — a tumor of melanin-forming cells, and ranked as the most serious type of skin ... Read more

September 4, 2014September 4, 2014

New Handheld Device Allows Deeper Melanoma Screening

Melanoma, News

Researchers from Washington University in St. Louis have constructed a hand-held photoacoustic microscopy device that uses lasers and sound waves to measure how deep a melanoma tumor extends into the ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group